Related Experiment Videos
Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat
M Nakayama1, T Koyama, I Yamashita
1Department of Psychiatry and Neurology, Hokkaido University, School of Medicine, Sapporo, Japan.
Brain Research
|January 22, 1993
Summary
Repeated, escalating doses of methamphetamine caused a long-lasting reduction in dopamine uptake sites in rat brains. This study highlights the persistent neurotoxic effects of methamphetamine on dopamine transporters.
Area of Science:
- Neuroscience
- Pharmacology
- Neurotoxicology
Background:
- Methamphetamine (MA) abuse is a significant public health concern.
- Repeated MA administration is known to induce behavioral sensitization.
- The impact of escalating MA doses on dopamine (DA) uptake sites requires further investigation.
Purpose of the Study:
- To investigate the long-term effects of a specific escalating dose regimen of methamphetamine on dopamine uptake sites in the rat striatum.
- To determine if these effects persist after drug discontinuation.
Main Methods:
- Rats received escalating doses of methamphetamine (2.5-10 mg/kg) twice daily for 7 days.
- Dopamine uptake and GBR12935 binding were measured in striatal tissue 7 and 30 days post-treatment.
- Specific [3H]DA uptake and [3H]GBR12935 binding assays were employed.
Main Results:
- A 36% reduction in specific [3H]DA uptake was observed 7 days after the last MA dose.
- A 29% reduction in specific [3H]GBR12935 binding was demonstrated in the striatum.
- This reduction in dopamine uptake sites persisted even 30 days after discontinuing methamphetamine.
Conclusions:
- The escalating dose regimen of methamphetamine induces a significant and long-lasting decrease in striatal dopamine uptake sites.
- These findings suggest persistent neuroadaptations in the dopaminergic system following repeated exposure to methamphetamine.
- The observed long-lasting reduction in dopamine transporters may underlie some of the persistent behavioral effects of chronic methamphetamine use.